Natera, Inc. (NTRA)
Last updated: 2026-10-20 20:52:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Natera, Inc. (NTRA) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $405.97, with a market capitalization of $56.71B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $181.00 to $437.41. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$56.71B | |
$400.01 | |
$437.41 | |
$6.52 | |
$399.42 | |
773.33K | |
1.47M | |
-- | |
$437.41 | |
$181.00 | |
-- | |
2001-12-30 |
Natera, Inc. (NTRA) After-Hours Stock Price
Natera, Inc. (NTRA) is trading at $405.98 in after-hours trading as of 2026-10-20 20:48:00, up 1.64% ($6.56) from the regular-session close of $399.42.
After-hours trading shows how investors are pricing NTRA after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Natera, Inc. (NTRA) 7-Day Stock Price Change
Over the past seven days, Natera, Inc. (NTRA) moved from $400.71 to $405.97, representing a gain of 1.31% ($5.26).
The stock traded between $378.97 and $410.63 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.18 million shares, down versus the previous seven-day period, indicating lower trading activity.
NTRA 52-Week Price Position
Position in Range: 87.7%
NTRA is currently trading at $405.97, placing it 87.7% of the way from its 52-week low of $181.00 to its 52-week high of $437.41. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Natera, Inc. (NTRA)?
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Natera, Inc. Information
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 6140 |
| CEO | Steven Leonard Chapman |
| Founded | 2003 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Natera, Inc. (NTRA) Stock on MEXC
Eligible investors can buy real shares of Natera, Inc. (NTRA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Natera, Inc. (NTRA) stock price today?
2.Is NTRA stock going up or down today?
3.What is NTRA pre-market price?
4.What is NTRA after-hours price?
5.Is NTRA stock trading now?
6.Where does NTRA sit relative to its 52-week high and low?
7.What sector is Natera, Inc. in?
8.What is Natera, Inc.'s market capitalization and where is it listed?
9.How is NTRA valued in terms of P/E ratio and EPS?
10.Does Natera, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
NTRA Stock Calculator
Estimate the value between NTRA shares and USD.
NTRA Shares to USD
1.00 NTRA shares = 405.972 USD
Calculations are estimates based on the latest available price and are for reference only.


